FindTrial
Sign In

Effect of intravenous magnesium sulphate for intraoperative anaesthetic requirements for patients under monitored anesthesia care during hysteroscopy

Effect of intravenous magnesium sulphate for intraoperative anaesthetic requirements for patients under monitored anesthesia care during hysteroscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024596
Enrollment
Unknown
Registered
2019-07-18
Start date
2019-07-16
Completion date
Unknown
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial disorders

Interventions

control group:no
experimental group:magnesium sulphate

Sponsors

Affiliate Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Aged 18 to 55 years, ASA class I-II, patients scheduled for elective hysteroscopy.

Exclusion criteria

Exclusion criteria: Patients with uncontrolled hypertension, cardiac dysfunction (ejection fraction 150 umol/l), preoperative opioids use, neurological disorder, diabetes, morbid obesity (body mass index > 30), history of chronic pain, drugs or alcohol abuse.

Design outcomes

Primary

MeasureTime frame
Propofol and fentanyl requirements;—

Secondary

MeasureTime frame
Respiratory depression;Postoperative pain;PONV;—

Countries

China

Contacts

Public ContactJingyan Lin

North Sichuan Medical College

419931094@qq.com+86 15983771119

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 25, 2026